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ABSTRACT Norovirus (NoV) infections are a signiﬁcant health burden to society, yet
the lack of reliable tissue culture systems has hampered the development of appro-
priate antiviral therapies. Here we show that the NoV NS3 protein, derived from mu-
rine NoV (MNV), is intimately associated with the MNV replication complex and the
viral replication intermediate double-stranded RNA (dsRNA). We observed that when
expressed individually, MNV NS3 and NS3 encoded by human Norwalk virus (NV) in-
duced the formation of distinct vesicle-like structures that did not colocalize with
any particular protein markers to cellular organelles but localized to cellular mem-
branes, in particular those with a high cholesterol content. Both proteins also
showed some degree of colocalization with the cytoskeleton marker -tubulin. Al-
though the distribution of MNV and NV NS3s were similar, NV NS3 displayed a
higher level of colocalization with the Golgi apparatus and the endoplasmic reticu-
lum (ER). However, we observed that although both proteins colocalized in mem-
branes counterstained with ﬁlipin, an indicator of cholesterol content, MNV NS3 dis-
played a greater association with ﬂotillin and stomatin, proteins known to associate
with sphingolipid- and cholesterol-rich microdomains. Utilizing time-lapse epiﬂuores-
cence microscopy, we observed that the membrane-derived vesicular structures in-
duced by MNV NS3 were highly motile and dynamic in nature, and their movement
was dependent on intact microtubules. These results begin to interrogate the func-
tions of NoV proteins during virus replication and highlight the conserved properties
of the NoV NS3 proteins among the seven Norovirus genogroups.
IMPORTANCE Many mechanisms involved in the replication of norovirus still remain
unclear, including the role for the NS3 protein, one of seven nonstructural viral pro-
teins, which remains to be elucidated. This study reveals that murine norovirus
(MNV) NS3 is intimately associated with the viral replication complex and dsRNA. We
observed that the NS3 proteins of both MNV and Norwalk virus (NV) induce promi-
nent vesicular structures and that this formation is dependent on microtubules and
cellular cholesterol. Thus, this study contributes to our understanding of protein
function within different Norovirus genogroups and expands a growing knowledge
base on the interaction between positive-strand RNA [()RNA] viruses and cellu-
lar membranes that contribute to the biogenesis of virus-induced membrane or-
ganelles. This study contributes to our understanding of viral protein function
and the ability of a viral protein to recruit speciﬁc cellular organelles and lipids
that enable replication.
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Noroviruses (NoVs) belong to the Caliciviridae family and are small, nonenveloped,positive-sense RNA viruses known to cause acute and chronic diseases in humans
(1, 2) and other mammals (3). The clinical symptoms of humans infected with NoV
include vomiting, abdominal cramps, and nonbloody loose or watery diarrhea that can
lead to severe dehydration (4, 5). NoV infections result in an estimated 230,000 deaths
per year, particularly in developing nations (6). This pathogen is highly infectious (7)
and transmitted primarily from person to person within enclosed settings such as
schools, cruise ships, hospitals, and aged-care and child care facilities (8, 9). NoV is the
only virus associated with global pandemics of acute gastroenteritis that emerge every
2 to 3 years, affecting hundreds of millions of people (10, 11). NoV pandemics have
occurred globally since the mid-1990s with increasing frequency (10–12). Conse-
quently, NoV-associated gastroenteritis has become a major public health concern for
which there is no available antiviral agent or preventative vaccine.
NoV host cell tropism appears to be exceptionally restricted (13); therefore, human
NoVs are difﬁcult to study due to the lack of a reliable cell culture system or any
small-animal models. Recently, it was observed that B cells could be infected with
human NoV but only in the presence of histo-blood group antigen-expressing enteric
bacteria, and infection was observed to be inefﬁcient (14). Subsequently, multiple
human NoV strains have been more robustly cultivated in stem cell-derived enterocytes
forming human intestinal enteroid monolayer cultures (15). Consequently, the molec-
ular mechanisms of human NoV pathogenesis and immunity remain poorly deﬁned (5).
In 2003, murine norovirus (MNV) was discovered and has been used to study the
immunity and pathogenesis of NoV infection in a mouse model (16). Subsequently, the
tropism of MNV for mononuclear cells was identiﬁed and led to the establishment of
the ﬁrst in vivo culture system to study NoV replication, a signiﬁcant advancement in
NoV biology (17).
NoV harbors an RNA genome of 7,500 nucleotides that is protein linked at the 5=
end by VPg (encoded by the viral gene NS5), polyadenylated at the 3= end, and divided
into 3 open reading frames (ORFs) (4 for MNV). ORF1 encodes a large polyprotein that
undergoes proteolytic cleavage by the virus-encoded protease (NS6) to produce the
mature viral nonstructural proteins (18). The two structural proteins, VP1 (major capsid
protein) and VP2 (minor capsid protein), are encoded by ORF2 and ORF3, respectively,
and can be additionally translated from a viral subgenomic RNA (18). Importantly, the
ORF1/ORF2 overlap has been shown to be the breakpoint for genetic recombination
(19–22).
Our group has been instrumental in identifying and interrogating the intracellular
site of MNV replication (20, 21). We have shown that the MNV replication complex (RC)
is a collection of irregular-sized vesicles tightly associated with the endoplasmic
reticulum (ER), the trans-Golgi network, endosomes, and the centrosome (20, 22). In
addition, we have identiﬁed the discrete intracellular localization patterns of the MNV
ORF1 proteins and their relationship with cellular organelles and membranes utilized
during MNV replication (23). We showed that MNV NS1-2 localizes to the ER, NS4
localizes to endosomes, and NS6 localizes to mitochondria (23). Interestingly, NS3
induced discrete vesicular structures that were unidentiﬁable by typical cell organelle
markers but showed some association with microtubules (23, 24).
In this study, we aimed to further investigate the function of MNV NS3 during the
replication cycle and the origin of the vesicular structures induced by MNV NS3
expression, comparing it to the expression pattern of human NoV (Norwalk virus [NV])
NS3. We show that MNV NS3 is intimately associated with double-stranded RNA
(dsRNA) within the MNV RC and show that the localization pattern of transiently
expressed human NV NS3 is similar to that of MNV NS3, although there are some subtle
differences. Additionally, we show that the vesicular structures induced during NS3
expression contain lipids, and using time-lapse epiﬂuorescence microscopy, we dem-
onstrate that these structures are highly dynamic and undergo microtubule-dependent
transport.
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RESULTS
The MNV NS3 protein localizes to the cytoplasmic face of membranes com-
prising the MNV replication complex. In our previous studies, we showed by immu-
noﬂuorescence (IF) analysis that MNV NS3 localized with dsRNA in the perinuclear
region of infected cells over the course of infection (25). Thus, we aimed to utilize
ultramicrotomy and immunogold labeling to address the speciﬁc localization of NS3
within MNV-infected cells. As shown in Fig. 1, membrane vesicles comprising the MNV
FIG 1 The MNV NS3 protein associates with the viral replication complex. Thawed cryosections of MNV-infected RAW264.7 cells were ﬁxed at 12 h p.i. (A and
B), 18 h p.i. (C and D), or 24 h p.i. (E and F) and were immunolabeled with anti-NS3 antibodies and 10-nm protein A gold. Bars, 200 nm in all cases.
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RC were heavily decorated with anti-NS3 antibodies during the course of infection. At
all time points investigated (namely, 12, 18, and 24 h postinfection [p.i.]), NS3 labeling
was observed to be intimately associated with the membranes comprising the RC. In
particular, the majority of the labeling of NS3 was conﬁned to the RC, and we observed
very little labeling in other areas of the cell. The localization of NS3 to the RC is not
surprising, as it contains helicase and nucleoside triphosphatase (NTPase) motifs that
are characteristic of an enzyme involved in positive-strand RNA virus replication (16).
To determine the precise localization of NS3 with dsRNA, we dually labeled thawed
cryosections obtained from MNV-infected cells with antibodies to dsRNA and NS3 that
were subsequently conjugated with 5-nm and 10-nm protein A-gold particles, respec-
tively (Fig. 2). As can be observed, the smaller 5-nm gold particles, corresponding to
labeling for dsRNA, were consistently associated with NS3 (larger 10-nm gold particles)
within the vesicles comprising the MNV RC. Interestingly, a majority of the labeling for
dsRNA was associated with cytoplasmic components morphologically similar to NS3,
with some labeling also being observed on the luminal side of the RC membranes.
These results suggest that MNV NS3 is abundant in the RC at the site of active viral
RNA replication.
Comparative analysis of the Norwalk virus and murine norovirus NS3 proteins.
In our attempts to determine the potential function and distribution of NoV NS3, we
aimed to compare the expressions and distributions of genogroup I (Norwalk) and
FIG 2 The MNV NS3 protein associates with dsRNA within the viral replication complex. Thawed cryosections of MNV-infected RAW264.7 cells ﬁxed at 12 h p.i.
(A and B) and 18 h p.i. (C and D) were dually labeled with antibodies to dsRNA (5-nm protein A gold) and NS3 (15-nm protein A gold). Arrowheads indicate
areas enriched for both the 5-nm and 10-nm gold particles corresponding to immunolabeling for dsRNA and NS3. RC; replication complex. Bars, 200 nm in all
cases.
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genogroup V (murine) NoV NS3 proteins. Initially, we compared the biochemical
characteristics of each protein (Fig. 3). We aligned the amino acid sequence of each
protein by ClustalW (Fig. 3A), with dark shading corresponding to identical amino acids
and light shading corresponding to conserved amino acids. PROSITE scanning analysis
FIG 3 Comparative analysis of the Norwalk virus and murine norovirus NS3 proteins. (A) ClustalW alignment of the amino acid sequences of NV NS3
(GenBank accession no. NP_786946) and MNV NS3 (accession no. YP_724457), with the dark shading corresponding to identical amino acids and light shading
corresponding to conserved amino acids. (B) PROSITE scanning of the NV andMNV NS3 amino acid (aa) sequences reveals a conserved SF3_Helicase motif in both
proteins. (C) TMpred prediction of transmembrane regions of each protein indicates a potential transmembrane alpha-helix within the N termini of both proteins.
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of the NV and MNV NS3 amino acid sequences additionally revealed a conserved
superfamily 3 helicase (SF3_Helicase) motif in both proteins (Fig. 3B), and further
TMpred prediction of transmembrane regions of each protein indicates a potential
transmembrane alpha-helix within the N terminus of both proteins (Fig. 3C).
Overall, these analyses revealed that there is a high degree of conservation between
these two proteins at the amino acid level, implying a potential conserved function
during the replication cycles of both NV and MNV.
Transient expression of either mouse or human NoV NS3 induces cytoplasmic
vesicular structures that display colocalization with the Golgi apparatus and
microtubules. We previously transiently expressed MNV NS3 from a recombinant
cDNA expression plasmid and determined its intracellular localization (23). In this study,
we aimed to determine if MNV and human genogroup I NoV strain NV NS3 shared the
same localization pattern and thus potential function in cells. Due to the lack of NV
NS3-speciﬁc antibodies, we generated expression vectors encoding recombinant NV
with a C-terminal c-Myc epitope tag and MNV NS3 with a C-terminal 6His epitope tag
(23) for comparative analysis, which were expressed in Vero cells and used to assess and
compare their intracellular localizations by IF analysis. As shown in Fig. 4, both NS3
proteins were expressed well in transfected cells and were recognized by antibodies
speciﬁc to their recombinant tag. The MNV and NV NS3 proteins displayed striking
similarity in their localization patterns. Both proteins induced a vesicular staining
pattern (Fig. 4, arrows), with some additional strong perinuclear staining for NV NS3 and
FIG 4 Both MNV NS3 and NV NS3 show a vesicular pattern upon transfection. Vero cells were transfected
with either MNV NS3- or NV NS3-containing plasmids and ﬁxed at 24 h p.t., and their localization was
assessed by IF analysis. Both proteins were expressed well in transfected cells and were recognized by
antibodies speciﬁc to their recombinant tag (MNV NS3-His [a and b] and NV NS3–c-myc [c and d]). Both
the MNV and NV NS3 proteins displayed similar localization patterns, and both proteins induced a
vesicular staining pattern (indicated by arrows). Additional strong perinuclear staining was observed for
NV NS3, and cytoplasmic reticular staining was observed for both proteins. This staining pattern for NV
NS3 was consistent with what we previously described for MNV NS3 (23).
Cotton et al. Journal of Virology
February 2017 Volume 91 Issue 3 e02138-16 jvi.asm.org 6
 o
n
 February 14, 2017 by W
ashington University in St. Louis
http://jvi.asm.org/
D
ow
nloaded from
 
cytoplasmic reticular staining for both proteins. This similarity of the cellular distribu-
tion patterns for the two NS3 proteins was consistent with a conserved function.
In our previous studies, we aimed to determine the intracellular localization of MNV
NS3 and observed very little colocalization of MNV NS3 with markers for known
organelles (23), with the exception of some association with mitochondria and micro-
tubules (24). To determine whether this was also true for NV NS3, we compared the
intracellular staining pattern of NV NS3 with those of cellular markers for speciﬁc
organelles, namely, protein disulﬁde isomerase (PDI) (for the rough endoplasmic retic-
ulum [rER]), GM130 (for the Golgi apparatus), early endosome antigen 1 (EEA1) (for
endosomes), and -tubulin (for microtubules) (Fig. 5). As can be observed, MNV NS3,
like NV NS3, showed little colocalization with markers for the ER and endosomes
(Pearson’s correlation [Rr]  0.43  0.13 and Rr  0.35  0.14, respectively) (Fig. 5a to
d and i to l). However, we observed colocalization of NV NS3 with the Golgi apparatus
and -tubulin (Rr  0.59  0.09 and Rr  0.30  0.09, respectively) (Fig. 5e to h and
m to p). In fact, the high level of colocalization of NV NS3 with GM130 was quite striking
and in contrast to that observed for MNV NS3 (23). However, it should be noted that the
morphology of the Golgi apparatus stained with GM130 indicates that it is still intact
FIG 5 NV NS3 displays signiﬁcant colocalization with PDI (n 50), GM130 (n 49), and -tubulin (n 33). Vero cells were
transfected with an NV NS3-containing plasmid and ﬁxed at 24 h p.t., and localization was assessed by IF analysis. Shown
is a comparison of the intracellular staining pattern of NV NS3 with those of cellular markers for speciﬁc organelles, namely,
PDI (for the rER), GM130 (for the Golgi apparatus), EEA1 (n  50) (for endosomes), and -tubulin (for microtubules). MNV
NS3, like NV NS3, showed little colocalization with markers for the ER and endosomes (a to d and i to l). However, we
observed colocalization of NV NS3 with the Golgi apparatus and microtubules using -tubulin (e to h and m to p). dapi,
4=,6-diamidino-2-phenylindole.
Norovirus NS3 Protein—Lipids and Microtubules Journal of Virology
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and not dispersed, similarly to our previous observations with MNV NS3 (23). We also
noted that although Pearson’s coefﬁcient of colocalization between NS3 and -tubulin
was below the threshold value of 0.5, this discrepancy relates to Rr values calculated for
localization in the entire cell rather than colocalization only in the perinuclear region.
These results indicate that when expressed individually, both the MNV and NV NS3
proteins have similar localization patterns, and most likely properties, in transfected
cells. These results suggest that, at least for NS3, the functions of this protein are similar
between the two genogroups, although some differences were observed, particularly
at the level of the localization of NV NS3 within the Golgi apparatus. These observations
also support the notion that the events of intracellular replication of MNV and NV may
be similar.
MNV and NV NS3 associate with cholesterol-rich membranes. As we observed
minimal colocalization of NS3 with any cellular organelles, except the Golgi apparatus
and microtubules, we additionally aimed to determine if NS3 was associated with lipids.
To investigate this, we initially stained NS3-transfected cells with the fungal metabolite
ﬁlipin, which stains cholesterol in membranes (Fig. 6). As observed in mock-transfected
FIG 6 Both MNV NS3 and NV NS3 vesicular structures colocalize with ﬁlipin cholesterol stain upon transfection. Vero cells
were transfected with either MNV NS3- or NV NS3-containing plasmids, ﬁxed at 24 h p.t., and stained with ﬁlipin. In
mock-transfected cells, ﬁlipin staining was conﬁned to the plasma membrane and also foci within the cytoplasm and
perinuclear region, which are characteristic of the trans-Golgi network and endosomes. Transfection of cells with either NV
NS3–c-myc or MNV NS3-His resulted in signiﬁcant colocalization of NS3 proteins, with ﬁlipin surrounding the NS3 vesicles
(f and i [n  15 and n  20, respectively]). In all cases, the anti-6His and anti-c-myc antibodies were detected with
species-speciﬁc antibodies conjugated to Alexa Fluor 488, and the ﬁlipin stain naturally ﬂuoresces blue. Pearson’s
coefﬁcient values are provided in the merged panels, with a value of 0.500 corresponding to colocalization.
Cotton et al. Journal of Virology
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cells, ﬁlipin staining (Fig. 6, blue) was conﬁned to foci within the cytoplasm and the
perinuclear region, most likely representing the site of the trans-Golgi network and
endosomes. Interestingly, for cells transfected with MNV NS3, we observed a signiﬁcant
colocalization with ﬁlipin that appeared to surround the NS3 vesicles (Rr 0.75 0.10)
(Fig. 6d to f). Additionally, we observed an accumulation of ﬁlipin staining within some
foci, perhaps evidence that it was recruited there by the introduction of NS3, as the
distribution differs from that in mock-transfected cells. In contrast, we observed a
limited degree of colocalization of NV NS3-induced vesicular structures with the ﬁlipin
stain (Rr  0.50  0.10) (Fig. 6g to i).
This may suggest that the MNV and NV NS3 proteins inherently associate with
intracellular lipids in different manners, which may impact their underlying functions
within the host cell during virus replication and RC establishment.
MNV NS3 associates with stomatin and ﬂotillin, resident host proteins within
cholesterol microdomains. To investigate the association of NoV NS3 with cholesterol
further, we cotransfected Vero cells with cDNA plasmids encoding MNV or NV NS3 and
green ﬂuorescent protein (GFP)-tagged stomatin/prohibitin/ﬂotillin/HfK/C (SPFH) pro-
teins. SPFH proteins are found to be enriched in lipid microdomains within different
organelles (26). Thus, we utilized GFP–erlin-1/2, GFP-prohibitin, GFP-stomatin, and
GFP-ﬂotillin to detect lipid-rich microdomains in the ER, mitochondria, endosomes, and
endosomes/plasma membrane, respectively. We did not observe any association be-
tween MNV or NV NS3 and GFP–erlin-1/2 or GFP prohibitin (data not shown). However,
we observed signiﬁcant colocalization of MNV NS3 with stomatin and ﬂotillin (Rr 
0.68  0.13 and Rr  0.48  0.15, respectively) (Fig. 7A to F). Interestingly, MNV NS3
predominantly associated with stomatin-GFP, particularly within the vesicular struc-
tures induced within the cytoplasm (Fig. 7D to F). In contrast, NV NS3 displayed less of
an association with these proteins (Rr  0.39  0.14 and Rr  0.29  0.15 for
ﬂotillin-GFP and stomatin-GFP, respectively) (Fig. 7G to I), although some colocalization
between NV NS3 and ﬂotillin-GFP in the perinuclear region was also observed (Fig. 7G
to I). These results suggest that MNV NS3 may have the propensity to locate to lipid-rich
microdomains within the endocytic pathway and again support a difference in the
localization of the MNV and NV NS3 proteins.
Depletion of cellular cholesterol by lovastatin and not methyl--cyclodextrin
alters NS3 vesicle formation. To further investigate the relationship between lipids
and NS3, cells were transfected with either MNV or NV NS3 and treated with lovastatin
(10 M) or methyl--cyclodextrin (MCD) (10 g/ml). Lovastatin inhibits the synthesis
of new cholesterol within the cell via the inhibition of hydroxyl-methylglutaryl-
coenzyme A reductase (HMGCR), whereas treatment with MCD reduces cellular levels
of cholesterol at the plasma membrane via dissolution of lipids through inclusion
complexes. Treatment of MNV and NV NS3-transfected cells with lovastatin induced a
disruption of the formation of the vesicle structures and dispersion from the perinuclear
regions to a more scattered distribution within the cytoplasm (Fig. 8A to C and G to I).
In addition, labeling of both the MNV and NV NS3 proteins was observed as smaller
vesicles (or aggregations) following lovastatin treatment. In contrast, treatment of MNV
and NV NS3-transfected cells with MCD did not induce any signiﬁcant visible changes
in the NS3 distribution and vesicle structures (Fig. 8D to F and J to L), as the
NS3-induced vesicular structures were still clearly visible in treated cells. However, we
observed a reduction in the diffuse cytoplasmic NV NS3 labeling signal upon MCD
treatment (Fig. 8J to L).
This result suggests that the formation of NS3-induced vesicles requires active
cholesterol synthesis rather than redistribution or sequestration from intracellular sites,
including the plasma membrane.
NS3 vesicular structures fuse together and are highly motile, and their move-
ment is microtubule dependent. To determine if the MNV and NV NS3 vesicle
structures were dependent on microtubules for their localization and movement, we
transfected Vero cells with recombinant MNV and NV NS3 cDNA plasmids. At 6 h
posttransfection (p.t.), transfected cells were incubated in the presence of medium
Norovirus NS3 Protein—Lipids and Microtubules Journal of Virology
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containing 10 M the microtubule-destabilizing agent nocodazole (NOZ) and ﬁxed at
18 h p.t. for IF analysis. As shown in Fig. 9, the induction of vesicular structures and the
distribution of the MNV and NV NS3 proteins appeared dispersed throughout the
cytoplasm during NOZ treatment (Fig. 9D to F and J to L, respectively). The NS3 vesicles
appeared smaller than the large aggregations of NS3 observed in the absence of NOZ
FIG 7 Both MNV NS3 and NV NS3 vesicular structures colocalize with the lipid markers stomatin-GFP and
ﬂotillin-GFP. Vero cells were transfected with either MNV NS3- or NV NS3-containing plasmids, concurrently
transfected with either stomatin-GFP or ﬂotillin-GFP, and ﬁxed at 24 h p.t. Colocalization of both the MNV
and NV NS3 proteins with stomatin-GFP and ﬂotillin-GFP was observed. MNV NS3 predominantly associated
with stomatin-GFP, particularly within the vesicular structures induced in the cytoplasm (n  29) (D to F),
rather than ﬂotillin-GFP (n  29) (A to C). In contrast, NV NS3 appeared to associate more with ﬂotillin-GFP
in the perinuclear region (n  20) (G to I), although some colocalization was also observed with
stomatin-GFP (n  24) (J to L).
Cotton et al. Journal of Virology
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(Fig. 9A to C). Interestingly, remnants of the vesicular structures could still be observed,
yet the majority of the NS3 staining was not conﬁned to these foci, as previously
observed. Also notable was that we observed signiﬁcant colocalization of NV NS3 with
-tubulin during NOZ treatment (Rr of 0.50  0.22, compared to an Rr of 0.39  0.13
for MNV NS3) (Fig. 9D to F), suggesting a very tight association of NV NS3 with
microtubules.
FIG 8 Colocalization of both the MNV NS3 and NV NS3 vesicular structures with the cholesterol ﬁlipin stain
is disrupted after treatment with lovastatin (A to C and G to I [n  14 and 32, respectively]) but not
methyl--cyclodextrin (MBCD) (D to F and J to L [n  13 and 26, respectively]). At 6 h p.t., Vero cells were
transfected with either MNV or NV, treated with lovastatin (10 M) or methyl--cyclodextrin (10 g/ml) for
18 h, and ﬁxed at 24 h p.t. Treatment with lovastatin showed a disruption of the vesicle structures and
dispersion from the perinuclear regions with which they are usually associated. NS3 labeling appears to
represent smaller vesicles (or aggregations). Treatment with MCD did not show a visible effect on NS3
structures, although a reduction in the diffuse cytoplasmic NS3 labeling signal was apparent in MNV NS3
samples, and a small reduction in colocalization was observed, possibly due to an overall reduction of
cellular cholesterol levels.
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To further characterize the nature of the NS3 vesicular structures, we utilized a
recombinant version of MNV NS3 that was fused to Aequorea coerulescens green
ﬂuorescent protein (AcGFP) at its C terminus (see Materials and Methods for vector
construction). This allowed us to visualize the movement of the NS3 structures in real
time using time-lapse epiﬂuorescence microscopy and video capture. Vero cells were
transfected with the MNV NS3-GFP plasmid, and at 12 h p.t., images were collected at
intervals of 5 min until 24 h p.t. Over this time period, we observed that the MNV NS3
FIG 9 Both MNV NS3 and NV NS3 vesicular structures are dependent on microtubules and are disrupted upon nocodazole
(NOZ) treatment. Vero cells were transfected with recombinant cDNA plasmids encoding MNV NS3 and NV NS3 at 8 h p.t. Cells
were subsequently incubated with or without medium containing 10 M NOZ and ﬁxed at 24 h p.t. Both the MNV and NV NS3
proteins show a disruption of the regular vesicle-like structures in the presence of NOZ and an overall reduction in microtubule
association (D to F [n  17] and J to L [n  21]) compared to the untreated controls (A to C [n  15] and G to I [n  37]).
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vesicular structures moved at a rapid pace, particularly in the x and y axes but also in
the z axis (Fig. 10A; see also Movie S1 in the supplemental material). Additionally, we
observed that the smaller NS3-GFP vesicles often appeared to fuse with one another to
generate larger foci (Fig. 10A and Movie S1). Plotting of the movement of individual foci
(25 to 225 min) (Fig. 10A) of these vesicles with Imaris (Bitplane) revealed that a majority
of the vesicles remained motile throughout the viewing period. Data from the visual-
ization and analysis of this movement are consistent with microtubule-dependent
transport.
To further interrogate the role of microtubules in the formation and movement of
the NS3 vesicular structures, we transfected Vero cells with the recombinant cDNA
plasmid encoding MNV NS3-AcGFP, and at 7.5 h p.t., cells were subsequently incubated
with or without NOZ and visualized every 5 min from 8 to 12 h p.t. The movement of
the MNV NS3-GFP structures was imaged in real time by using time-lapse epiﬂuores-
cence microscopy and video capture. As demonstrated in Fig. 10B and Movies S1 and
S2 in the supplemental material, movement or trafﬁcking of the MNV NS3-AcGFP
vesicular structures was not evident in the NOZ-treated sample, nor was the formation
and fusion of larger NS3-AcGFP vesicles observed in the NOZ-treated sample, which we
presume to be caused by their lack of movement and also points to a microtubule-
dependent trafﬁcking mechanism (Fig. 10).
Microtubule disruption affects the localization of NS3 and dsRNA in MNV-
infected cells. To further investigate the effects of NOZ treatment during infection, we
performed IF analysis on the distribution of MNV NS3, -tubulin, and dsRNA in
MNV-infected RAW264.7 cells (Fig. 11). Cells were infected only and viewed for the
distribution of MNV NS3 (Fig. 11, red) and -tubulin (Fig. 11A to C, green) or dsRNA (Fig.
11G to I, green). MNV-infected cells were additionally treated with NOZ from 1 h p.i. and
viewed for the distribution of MNV NS3 (Fig. 11, red) and -tubulin (Fig. 11D to F, green)
or dsRNA (Fig. 11J to L, green). Although the overall distributions of NS3 and dsRNA
were affected by NOZ treatment, the association between both NS3 and -tubulin (Rr
of 0.47  0.14 [untreated] versus Rr of 0.46  0.15 [treated]) and NS3 and dsRNA (Rr of
0.83  0.08 [untreated] versus Rr of 0.74  0.11 [treated]) remained unaltered.
Overall, these results have shown that the vesicular structures induced by both the
MNV and NV NS3 proteins share similar properties; they are highly motile, and their
movement is microtubule dependent.
DISCUSSION
In this study, we have compared the intracellular localizations of the genogroup I NV
and the genogroup V MNV NS3 proteins. Overall, we showed that MNV NS3 is an
integral component of the MNV RC and closely associates with the replicative inter-
mediate dsRNA throughout the course of infection (Fig. 1 and 2). We observed that
both proteins share the ability to induce vesicular structures in the cytoplasm of
transfected cells, an induction that appears to be dependent on both cholesterol and
microtubules. Notably, both the NV and MNV NS3 proteins colocalize with microtubules
and, to a lesser extent, with cholesterol, implying that their roles during their respective
virus replication cycles are to recruit and/or utilize these host components to facilitate
efﬁcient virus replication. These observations are consistent with previous studies by
our group showing a reduction in viral titers following nocodazole treatment (24).
Interestingly, although we observed many similarities in the subcellular localizations of
the NV and MNV NS3 proteins, we observed a greater proportion of NV NS3 colocalizing
with the Golgi apparatus and microtubules than for MNV NS3, which exhibited more
extensive localization with cholesterol-rich membranes. All of these aspects are ex-
tremely relevant to MNV replication, as we have previously shown that the MNV
replication complex is housed within membranes derived from the endocytic pathway
and is centered on or around the microtubule organizing center (MTOC) and adjacent
to the Golgi apparatus. Furthermore, cholesterol has been observed to play a role in the
replication and entry of NV and MNV, respectively (27–29). Thus, the recruitment and
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FIG 10 (A) MNV NS3-GFP vesicular structures display regular movement upon transfection. Vero cells were transfected with an MNV NS3-GFP plasmid and
viewed over a 4-h period at 8 to 12 h p.t. NS3-GFP-transfected cells show movement of NS3-GFP vesicles throughout the cell. (A) Still images show the
movement of NS3-GFP over time (images shown were those collected every 25 min). The time-lapse merge panel shows tracking over an 4-h period at 8 to
12 h p.t., showing highly motile vesicle structures (with images being taken every 5 min) (see Movie S1 in the supplemental material). (B) MNV NS3-GFP vesicular
structures show a lack of movement upon NOZ treatment. Vero cells were transfected with an MNV NS3-GFP recombinant cDNA plasmid, and at 7.5 h p.t., cells
were subsequently incubated with medium containing 10 M NOZ and visualized from 8 to 12 h p.t. Still images show the movement of NS3-GFP over time
(images shown were those collected every 25 min). The time-lapse merge panel shows tracking over an4-h period at 8 to 12 h p.t. and was analyzed by using
IMARIS software, showing immotile GFP structures. NOZ-treated NS3-GFP-transfected cells show a lack of vesicle movement (with images being taken every
5 min) (Movie S2).
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potential redistribution of cholesterol may be required to facilitate these events in the
virus life cycle.
In addition, we observed that the vesicle structures induced during MNV NS3-GFP
expression displayed rapid movement when viewed via time-lapse epiﬂuorescence
microscopy. Throughout the course of expression, smaller individual vesicles appeared
to additionally aggregate into larger foci, implying that the vesicles are also fusogenic,
with the potential high cholesterol content contributing to the observed membrane
dynamics. Our previously reported observations identiﬁed a role for microtubules in the
FIG 11 IF analysis showing the effect of NOZ treatment on the distribution of MNV NS3, -tubulin, and dsRNA in
infected RAW264.7 cells. Cells were infected only and viewed for the distribution of MNV NS3 (red) and -tubulin
(green) (A to C) or dsRNA (green) (G to I). MNV-infected cells were additionally treated with NOZ at 1 h p.i. and
viewed for the distribution of MNV NS3 (red) and -tubulin (green) (D to F) or dsRNA (green) (J to L). The
distributions of NS3 and dsRNA are affected by NOZ treatment, and the associations between NS3 and -tubulin
(Rr of 0.47  0.14 [untreated] [n  21] versus Rr of 0.46  0.15 [treated] [n  23]) and between NS3 and dsRNA
(Rr of 0.83  0.08 [untreated] [n  20] versus Rr of 0.74  0.11 [treated] [n  19]) are unaltered.
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establishment and positioning of the MNV RC within cells (24), and this study indicates
that NS3 may facilitate the transport of the vesicles along microtubules during infec-
tion. Our current research is focused on investigating the role of cholesterol and lipid
transport during MNV replication, and these aspects are under investigation.
Our studies utilizing NOZ treatment also demonstrated that the trafﬁcking of MNV
NS3 is highly motile and facilitates the coalescence of the NS3 vesicular structures to
form larger membrane-rich aggregates. The use of the microtubular network as a
means of trafﬁcking viral components is not uncommon for viruses. Several RNA
viruses, such as hepatitis C virus (HCV), poliovirus, and rabies virus, have demonstrated
the use of microtubules in different ways to facilitate their replication (30–32). In the
case of MNV, we have demonstrated that the abrogation of microtubules via NOZ
treatment leads to a complete loss of vesicular movement and also the loss of the
ability to form larger aggregations of NS3 than those in untreated MNV NS3-GFP-
transfected cells. The exact purpose of these vesicles still remains unclear, although
their regular movement and vesicular shape would lend themselves to a trafﬁcking or
recruitment mechanism to aid viral replication. Previously, we observed that NOZ
treatment of MNV-infected cells resulted in the dispersion of the MNV RC (24); thus, NS3
may be the viral tether that trafﬁcs and positions the MNV RC proximal to the MTOC.
The colocalization of NS3 with cholesterol and lipid host cell components also
implicates a role for this protein in the recruitment of cellular membranes required for
viral RC formation, possibly via facilitating membrane curvature. We also observed
some colocalization of both the NV and MNV NS3 proteins with stomatin, although
MNV NS3 displayed a greater association, which has a strong association with the
phospholipid bilayer and actin within detergent-resistant membrane domains (33). This
suggests that NS3 may promote or disable the scaffold of these ordered domains, a
hypothesis that we are currently investigating.
We also observed an association of MNV NS3 and, to some extent, NV NS3 with
ﬂotillin, which is noted for forming microdomains in the plasma membrane and
providing a scaffold for membrane rafts (34) and also for forming microdomains in the
endocytic pathway, where it is known to localize to early/late endosomes (26). Al-
though we did not detect a great deal (if any) NS3 colocalization with early endosomes,
further work is focused on identifying and characterizing the role of other cellular
components of the endocytic pathways during NoV replication, as these components
are known to be utilized by many viruses to facilitate their replication. The observed
association of NoV replicative proteins with lipid-rich domains is in line with observa-
tions of many other positive-strand RNA [()RNA] viruses that enrobe their RC in
cellular membranes to avoid host cell detection and create a microenvironment to help
facilitate their own replication. Further studies with a plethora of endosomal and other
cytoplasmic markers, and more robust cell culture methods, may help to elucidate
other components involved with NS3 and NoV replication.
This study has shown that the previously uncharacterized NS3 protein is highly
motile upon transfection; unfortunately, we are unable to study it in its “native” state
due to the inability to generate a tagged NS3 protein with infectious clones thus far. We
have also demonstrated its association with lipids and cellular components, particularly
those of the Golgi apparatus and microtubules. There also appear to be subtle
differences between the localization of MNV NS3 and that of NV NS3, although both
proteins appear to be highly motile and dependent on intact microtubules to facilitate
their movement. Our results suggest that NS3 may act as a tether on microtubules and
recruit lipids (particularly cholesterol) to drive the biogenesis of the NoV RC.
MATERIALS AND METHODS
Viruses and cells. RAW264.7 and VeroC1008 cells were grown and maintained in Dulbecco’s
modiﬁed Eagle’s medium (DMEM) (Invitrogen, Australia) supplemented with 10% fetal calf serum (Lonza,
Basel, Switzerland), 2 mM GlutaMAX (Gibco BRL), and 100 U/ml penicillin–100 g/ml streptomycin (Gibco
BRL). RAW264.7 cells were infected with MNV strain CW1 (GenBank accession no. DQ285629.1) at a
multiplicity of infection (MOI) of 5, as previously described (17, 25), and infected cells were maintained
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in DMEM containing 10% fetal calf serum, 2 mM GlutaMAX, and 100 U/ml penicillin–100 g/ml
streptomycin.
Reagents. MNV-speciﬁc guinea pig polyclonal antibodies were described previously (35). Anti-
rabbit-, anti-guinea pig-, and anti-mouse-speciﬁc IgG Alexa Fluor 488, 549, and 680 were purchased
from Molecular Probes (Invitrogen, Leiden, The Netherlands). Anti-dsRNA (clone J2) was purchased
from English & Scientiﬁc Consulting BT (Hungary). Protein A-gold (5, 10, and 15 nm) was pur-
chased from Utrecht University (Utrecht, The Netherlands). Mouse polyclonal anti--tubulin was
purchased from Sigma-Aldrich (St. Louis, MO, USA). Rabbit polyclonal anti-PDI, rabbit polyclonal anti-
calnexin, rabbit polyclonal anti-GM130, and mouse polyclonal anti-6His were purchased from Merck-
Calbiochem (Germany). Rat polyclonal anti-c-myc and rabbit polyclonal anti-EEA1 were purchased from
Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA). Rabbit polyclonal anti-6His was purchased from
Abcam (USA). Lovastatin, methyl--cyclodextrin, and nocodazole were purchased from Sigma-Aldrich (St.
Louis, MO, USA). Lipofectamine 2000 reagent was purchased from Invitrogen. Recombinant cDNA
plasmids expressing enhanced GFP (eGFP)-tagged erlin-1, erlin-2, prohibitin, stomatin, and ﬂotillin were
kindly provided by Stephen Robbins (University of Calgary, Canada) (36).
Construction of pcDNA3.1-MNV-NS3-GFP and pcDNA3.1-NV-NS3-cmyc. For the construction of
pcDNA3.1-MNV-NS3-GFP, which expresses a C-terminally fused NS3-AcGFP protein, a DNA fragment
corresponding to the NS3 gene was ampliﬁed by PCR from p20.3 DNA (37) using the Elongase
ampliﬁcation system (Invitrogen), forward primer frwNS3.GFP (5=-TATATATTTACTCGAGCCACCATGGGG
CCCTTCGACCTTGCTCTTGACGTGGTGCCC-3=), and reverse primer revNS3.GFP (5=-TAAAATTATTGGATCCT
GGAGGCCGAAATCATCATGGCGCTCATGGACAAGAGCAACCGCTC-3=). Primer frwNS3.GFP was designed to
introduce an XhoI restriction site (underlined) and the ﬁrst AUG codon (in boldface type) upstream of the
NS3 sequence. Reverse primer revNS3.GFP contained a sequence complementary to the 3= end of the
NS3 gene and an engineered BamHI site (underlined). The gel-puriﬁed PCR fragment was cleaved with
XhoI and BamHI and ligated into the compatible sites of the pAcGFP1-N1 vector (Clontech). The resulting
plasmid contained the MNV-1 NS3 sequence fused at the C terminus to the AcGFP protein under the
control of a cytomegalovirus (CMV) promoter.
The construction of pcDNA3.1-NV-NS3-cmyc was performed essentially as described above; however,
a DNA fragment corresponding to the NV NS3 gene was ampliﬁed by PCR from pNV-Neo (38) using Pfu
polymerase (Promega), forward primer frwHuNS3 (5=-GCCACCATGGGACCCGAGGACTTG-3=), and reverse
primer revHuNS3 (5=-TATCTCGAGTTACTGGAGTTGGAACTC-3=). The gel-puriﬁed PCR fragment was
cleaved with XhoI and ligated into the pcDNA3.1 vector (Life Technologies) digested with XhoI and
EcoRV. The resulting plasmid contained the NV NS3 sequence fused at the C terminus to the c-myc
protein under the control of a CMV promoter.
Immunoﬂuorescence analysis. RAW264.7 cell monolayers on coverslips were infected with MNV at
an MOI of 5 and incubated at 37°C for different time periods postinfection. VeroC1008 cell monolayers
on coverslips were transfected with pcDNA3.1 fusion plasmids and Lipofectamine 2000 as speciﬁed by
the manufacturer and incubated at 37°C for the speciﬁed periods posttransfection. The cells were
subsequently washed with phosphate-buffered saline (PBS), ﬁxed with 4% paraformaldehyde
(ProSciTech, Kirwan, Australia) for 10 min at 20°C, and permeabilized with 0.1% (vol/vol) Triton X-100 in
4% (vol/vol) paraformaldehyde for an additional 10 min at 20°C; the cells were then processed for IF
analysis, as previously described (23). After a ﬁnal wash with PBS, the coverslips were drained and
mounted onto glass slides with quick-dry Ultramount mounting medium (United Biosciences, Brisbane,
Australia) before visualization on a Zeiss LSM 710 confocal microscope. Images were collected from a
single plane with a 60 objective and a numerical aperture of 1.4. The images were subsequently
collated by using Zeiss Zen and Adobe Photoshop software, with all images being taken under identical
acquisition settings. Colocalization was determined by Pearson’s coefﬁcient using ImageJ JACoP plug-in
software. A coefﬁcient value exceeding 0.500 is considered colocalization.
Time-lapse epiﬂuorescence microscopy. VeroC1008 cell monolayers on Fluorodish dishes (World
Precision Instruments, USA) were transfected with the pcDNA3.1-MNV-NS3-GFP fusion plasmid and
Lipofectamine 2000, as speciﬁed by the manufacturer, and incubated at 37°C for the speciﬁed periods
posttransfection. The cells were subsequently left untreated or treated with 10 M nocodazole for 30 min
at 37°C prior to viewing on a Zeiss 700 confocal microscope for the speciﬁed time periods. Images were
collected and collated by using Zeiss Zen, Bitplane Imaris, and Adobe Photoshop software.
Electron microscopy. Methods for cryoﬁxation, preparation of cryosections, and immunolabeling
were described previously (24, 27, 28). Brieﬂy, MNV-infected cells were ﬁxed with 4% paraformaldehyde–
0.1% glutaraldehyde (ProSciTech, Kirwan, Australia) in PBS on ice for 60 min and subsequently embedded
within a 10% gelatin block before postﬁxing with 1% paraformaldehyde in PBS. The sample blocks were
infused with a mixture of sucrose and polyvinylpyrrolidone and mounted onto cryostubs (Leica) for
cryosectioning. Ultrathin cryosections (55 nm) were cut with a Diatome Cryo-P diamond knife and
retrieved from the cryochamber with a droplet of a 14:1 dilution of 2.3 M sucrose–2% methylcellulose.
The recovered sections were subsequently immunolabeled with the appropriate antibodies and protein
A-gold and contrasted with 1.8 M methylcellulose containing 0.4% uranyl acetate. The sections were then
viewed on a JOEL 1010 transmission electron microscope, and images were captured with a MegaView
III side-mounted charge-coupled-device (CCD) camera (Soft Imaging Systems, USA) and processed with
Adobe Photoshop.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/
JVI.02138-16.
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VIDEO S1, MOV ﬁle, 0.3 MB.
VIDEO S2, MOV ﬁle, 6.0 MB.
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